European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 38-42 , January 2009

Prognosis of women with pT4b breast cancer: The significance of this category in the TNM system

,Accepted 28 November 2007.

References 

  1. In:  Sobin LH,  Wittekind C editor. TNM classification of malignant tumors. 6th ed.. New York: John Wiley & Sons, Inc; 2002;
  2. In:  Wittekind C,  Henson D,  Hutter R,  Sobin L editor. TNM supplement: a commentary on uniform use. 2nd ed.. New York: John Wiley & Sons, Inc; 2001;
  3. Shukla H, Hughes L, Gravelle I, Satir A. The significance of mammary skin edema in noninflammatory breast cancer. Ann Surg. 1979;189:53–57
  4. Zucali R, Kenda R. Small size T4 breast cancer: natural history and prognosis. Tumori. 1981;67:225–230
  5. El-Tamer M, Hussain S, Weedon J. Prognoses of T4 breast cancer subsets. Ann Surg Oncol. 2002;9:340–345
  6. Güth U, Moch H, Herberich L, Holzgreve W. Noninflammatory breast carcinoma with skin involvement. Cancer. 2004;100:470–478
  7. Güth U, Singer G, Schötzau A, et al. Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement (T4b): a clinicopathologic study and an international survey. Ann Oncol. 2005;16:1618–1623
  8. Güth U, Wight E, Schötzau A, et al. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon a historic relic from the TNM classification. Cancer. 2005;104:1862–1870
  9. Güth U, Singer G, Langer I, et al. T4 category revision enhances the accuracy and significance of stage III breast cancer. Cancer. 2006;106:2569–2575
  10. Güth U, Wight E, Schötzau A, et al. A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol. 2006;45:576–583
  11. Güth U, Wight E, Schötzau A, et al. Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b). Hum Pathol. 2006;37:264–271
  12. Wieland A, Louwman M, Voogd A, Van Beek M, Vreugdenhil G, Roumen R. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J. 2004;10:123–128
  13. Shen J, Valero V, Buchholz T, et al. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004;11:854–860
  14. Poole G, Thigpen J, Vance R, Barber W. Management of women who present with T4 breast cancer. Am Surg. 2004;70:662–667
  15. Newman L. Management of patients with locally advanced breast cancer. Curr Oncol Rep. 2004;6:53–61
  16. Gajdos C, Tartter P, Estabrook A, Gistrak M, Jaffer S, Bleiweiss I. Relationship of clinical and pathological response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol. 2002;80:4–11
  17. Mamounas E. Editorial: tailoring loco-regional therapy with neoadjuvant chemotherapy: another step in the right direction. Ann Surg Oncol. 2004;11:888–891
  18. Asoglu O, Muslumanoglu M, Igci A, et al. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Acta Chir Belg. 2005;105:62–68
  19. Chen A, Meric-Bernstam F, Hunt K, et al. Breast conservation after neoadjuvant chemotherapy: the M.D. Anderson Cancer Center experience. J Clin Oncol. 2004;22:2303–2312
  20. Busch E, Kemeny M, Fremgen A, Osteen R, Winchester D, Clive R. Patterns of breast cancer care in the elderly. Cancer. 1996;78:101–110
  21. Goodwin J, Hunt W, Samet J. Determinants of cancer therapy in elderly patients. Cancer. 1993;72:594–601
  22. Samet J, Hunt C, Key C, Humble C, Goodwin J. Choice of cancer therapy varies with the age of the patient. J Am Med Assoc. 1986;255:3385–3390

PII: S0748-7983(07)00659-2

doi: 10.1016/j.ejso.2007.11.016

European Journal of Surgical Oncology
Volume 35, Issue 1 , Pages 38-42 , January 2009